Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flutemetamol (18F) Specificity in Healthy Young Adults
NCT01265394Phase 3Completed
- Sponsor
- GE HealthCare
- Start
- Dec 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of flutemetamol in Alzheimer's disease (AD), sponsored by GE HealthCare. Started Dec 2010; status: completed.
02
Drugs
flutemetamol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01265394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265394.